1. Home
  2. CDNA vs AVAH Comparison

CDNA vs AVAH Comparison

Compare CDNA & AVAH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CareDx Inc.

CDNA

CareDx Inc.

HOLD

Current Price

$19.08

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo Aveanna Healthcare Holdings Inc.

AVAH

Aveanna Healthcare Holdings Inc.

HOLD

Current Price

$8.38

Market Cap

1.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CDNA
AVAH
Founded
1998
1984
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Hospital/Nursing Management
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.9B
IPO Year
2014
2021

Fundamental Metrics

Financial Performance
Metric
CDNA
AVAH
Price
$19.08
$8.38
Analyst Decision
Buy
Buy
Analyst Count
7
9
Target Price
$26.67
$10.19
AVG Volume (30 Days)
778.2K
1.1M
Earning Date
11-04-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.22
0.37
Revenue
$357,998,000.00
$2,290,591,000.00
Revenue This Year
$14.11
$20.08
Revenue Next Year
$11.75
$7.12
P/E Ratio
$15.80
$22.75
Revenue Growth
14.46
15.48
52 Week Low
$10.96
$3.67
52 Week High
$25.95
$10.32

Technical Indicators

Market Signals
Indicator
CDNA
AVAH
Relative Strength Index (RSI) 53.43 36.40
Support Level $19.01 $8.56
Resistance Level $20.61 $9.27
Average True Range (ATR) 0.78 0.26
MACD -0.19 -0.07
Stochastic Oscillator 17.62 12.79

Price Performance

Historical Comparison
CDNA
AVAH

About CDNA CareDx Inc.

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.

About AVAH Aveanna Healthcare Holdings Inc.

Aveanna Healthcare Holdings Inc is a diversified home care platform that provides care to medically complex, high-cost patient populations. It directly addresses the pressing challenges facing the U.S. healthcare system by providing safe, high-quality care in the home. The firm provides its services through three segments: Private Duty Services (PDS); Home Health & Hospice (HHH); and Medical Solutions (MS). Private Duty Services include private duty nursing (PDN) and pediatric therapy services. Revenue is derived from pediatric healthcare services provided to patients including private duty nursing and therapy services, adult home health and hospice services (collectively patient revenue) and from the delivery of enteral nutrition and other products to patients.

Share on Social Networks: